3495-35-0 Usage
Description
Rubidium formate hydrate is a chemical compound with the formula Rb(HCOO), which is a white crystalline solid. It is a formate salt of rubidium and is known for its unique properties and applications across various industries.
Uses
Used in Anticancer Applications:
Rubidium formate hydrate is used as a compound in the development of anticoagulants, which are essential in preventing blood clots and managing various medical conditions related to blood clotting disorders.
Used in Dental Materials:
In the dental industry, rubidium formate hydrate is utilized as a component in the formulation of dental materials, such as cements and fillings, due to its ability to enhance the properties of these materials and improve their performance.
Used in Indicators and Reagents:
Rubidium formate hydrate is also employed as an indicator and reagent in various chemical and analytical processes. Its unique properties make it suitable for use in a range of applications, including pH measurements and other analytical techniques.
Check Digit Verification of cas no
The CAS Registry Mumber 3495-35-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,9 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3495-35:
(6*3)+(5*4)+(4*9)+(3*5)+(2*3)+(1*5)=100
100 % 10 = 0
So 3495-35-0 is a valid CAS Registry Number.
InChI:InChI=1/CH2O2.Rb/c2-1-3;/h1H,(H,2,3);/q;+1/p-1
3495-35-0Relevant articles and documents
Structural studies on the phase transition of rubidium formate
Masuda, Yoshio,Morita, Wataru,Yahata, Akihiko,Yukawa, Yasuhiko
, p. 39 - 43 (1998)
The thermal phase transition of rubidium formate, observed at 363 K, was studied by means of thermal analysis and X-ray diffraction method. The transition was found to be a reversible first-order transition. In the phase transition, the orthorhombic phase (Pca21) with lattice constants a=9.229(1), b=4.630(2) and c=7.408(2) A, was transformed to the monoclinic phase (P21/m) with one of a=4.6552(4), b=4.6528(7), c=7.5170(6) A and γ=97.610(6)°. The values of the enthalpy, ΔHtr, and entropy change, ΔStr, for the transition were 0.42±0.02 kJ mol-1 and 1.16±0.05 J K-1 mol-1, respectively. Although the relative positions of rubidium atoms hardly changed in the phases before, and after, the transition, the orientation of formate ions differed in both the phases. The values of ΔHtr and ΔStr seem to reflect a slight change of structure in the orientation of formate ions.
Novel Synthesis of Oxalate from Carbon Dioxide and Carbon Monoxide in the Presence of Caesium Carbonate
Kudo, Kiyoshi,Ikoma, Futoshi,Mori, Sadayuki,Komatsu, Koichi,Sugita, Nobuyuki
, p. 633 - 634 (2007/10/02)
In the presence of caesium carbonate 1, the direct reaction of CO2 (110 atm) with CO (20 atm) results in reductive capture of CO2 to give caesium oxalate 2 in good yield at elevated temperature (380 deg C).
